Related Experiment Video

Updated: May 28, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

Anaesthetic considerations in paediatric myasthenia gravis

Oliver William Masters1, Oliver N Bagshaw

  • 1Birmingham Children's Hospital, Birmingham B4 6NH, UK.

Autoimmune Diseases
|October 1, 2011
PubMed

Insights

Anesthesia management for myasthenia gravis (MG) is crucial due to its effects on neuromuscular function. This review covers MG pathophysiology, pharmacology, and anesthetic considerations for pediatric patients, including crisis management.

Area of Science:

  • Anesthesiology
  • Neurology
  • Pharmacology

Background:

  • Myasthenia gravis (MG) affects neuromuscular junctions, posing unique challenges for anesthesiologists.
  • Anesthetic drugs and MG treatments can interact, requiring careful management.
  • Pediatric patients with MG may need anesthesia for treatment or mechanical ventilation during crises.

Purpose of the Study:

  • To review the pathophysiology and pharmacology of myasthenia gravis.
  • To explore the relationship between MG and anesthetic management.
  • To discuss established and novel anesthetic techniques for MG patients.

Main Methods:

  • Comprehensive literature review.
  • Analysis of pathophysiology and applied pharmacology of myasthenia gravis.
  • Exploration of anesthetic management strategies.

Main Results:

  • Myasthenia gravis significantly impacts anesthetic choices due to neuromuscular junction involvement.
  • Understanding drug interactions is vital for safe anesthesia in MG patients.
  • Both traditional and emerging anesthetic approaches are relevant.

Conclusions:

  • Anesthesiologists must be knowledgeable about myasthenia gravis for optimal patient care.
  • Tailored anesthetic management is essential for pediatric patients with MG.
  • This review provides insights into current and future anesthetic practices for myasthenia gravis.

More Related Videos

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...